프레그네놀론 보충제 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 형태별, 유통경로별, 용도별, 지역별, 경쟁별(2020-2030년)

Global Pregnenolone Supplements Market was valued at USD 530.20 million in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.32% through 2030. Pregnenolone Supplements are dietary supplements that contain pregnenolone, a natural steroid hormone produced in the body. Pregnenolone serves as a precursor to various other hormones in the body, including estrogen, testosterone, progesterone, and cortisol. Pregnenolone is synthesized primarily in the adrenal glands, liver, skin, brain, and other tissues. Pregnenolone is considered a prohormone because the body can convert it into other hormones as needed. It can be transformed into sex hormones like estrogen and testosterone, as well as hormones related to stress and inflammation, such as cortisol. Pregnenolone Supplements are available in various forms, including capsules, tablets, creams, and sublingual (under the tongue) drops, allowing individuals to choose the method of administration that best suits their preferences.

The global population is aging, and with age comes various health concerns, including hormonal imbalances and cognitive decline. Pregnenolone is often marketed as a supplement to address these age-related issues. As the incidence of cognitive health issues such as memory loss and age-related cognitive decline increases, the demand for Pregnenolone Supplements, which are associated with cognitive support, rises. Hormonal imbalances can affect both men and women, leading to a range of symptoms. Pregnenolone is marketed as a potential solution for hormonal balance, attracting those seeking relief from these imbalances.

Key Market Drivers

Rising Aging Population

Aging can lead to hormonal imbalances, such as a decrease in sex hormones like estrogen and testosterone. Pregnenolone is a precursor to these hormones and is believed to help restore hormonal balance, making it appealing to individuals seeking relief from symptoms associated with hormonal changes. Cognitive decline is a common concern as people age. Pregnenolone is considered a neurosteroid and has been associated with potential cognitive benefits, including memory enhancement. This cognitive support aspect of Pregnenolone attracts individuals looking for ways to maintain or improve their cognitive function as they age. Many aging individuals are concerned about the risks and side effects associated with traditional hormone replacement therapy (HRT). Pregnenolone is often seen as a natural and milder alternative to HRT, which appeals to those who prefer a more natural approach to managing hormonal changes. As per the consumerLab's survey ranked over 200 supplements by usage. Vitamin D, magnesium, and omega-3s led, followed by coenzyme Q-10 (42.2%), multivitamins (41%), vitamin C (41%), probiotics (36.9%), zinc (34.3%), and vitamin B12 (34%). Curcumin ranked 11th (33%), with vitamin K, calcium, collagen, melatonin, protein, green tea, cocoa, quercetin, and apple cider vinegar trailing.

Key Market Challenges

Competition and Market Saturation

With many supplement manufacturers and brands offering Pregnenolone Supplements, the market can become highly competitive. This competition can lead to price wars and reduced profit margins, making it challenging for businesses to maintain profitability. Differentiating one's brand and products in a crowded market is challenging. Companies must invest in marketing, product quality, and unique value propositions to stand out and attract consumers. As the market becomes more competitive, ensuring consistent quality and purity of Pregnenolone Supplements becomes paramount. Manufacturers must maintain strict quality control measures to meet consumer expectations and comply with regulations. The abundance of product choices can lead to consumer confusion. With many brands and formulations available, consumers may find it difficult to select the right Pregnenolone Supplement for their needs. As the market becomes saturated with products, reaching new consumers can be challenging. Market saturation means that most potential consumers are already aware of the product, making it harder to expand the customer base. With so many products in the market, securing shelf space in physical stores or visibility online can be a hurdle for manufacturers. This can limit market access. Increased competition often leads to price pressure as manufacturers try to undercut each other. While this can benefit consumers, it may impact profit margins for businesses. To compete effectively, businesses may need to invest significantly in marketing and advertising to gain consumer attention. High marketing costs can strain smaller companies' budgets. In a competitive market, consumers may become more skeptical of product claims. Building trust and credibility becomes more critical in this environment.

Key Market Trends

Natural and Bio-Identical Ingredients

Natural and bio-identical ingredients are often considered safer and less likely to cause adverse effects or allergic reactions compared to synthetic alternatives. Consumers are increasingly seeking supplements with minimal side effects. Bio-identical ingredients are designed to be structurally identical to substances naturally occurring in the body. This can lead to better absorption and utilization by the body, making them more effective. There is a growing consumer preference for natural and minimally processed products across various industries, including dietary supplements. Pregnenolone Supplements formulated with natural ingredients align with this demand. Some consumers believe that natural and bio-identical ingredients are more effective in addressing health concerns because they closely resemble the body's own compounds. The use of natural ingredients may also be seen as more environmentally friendly, as it can reduce the need for chemical synthesis and processing. Natural and bio-identical ingredients are often associated with clean labeling and transparent product information. Consumers appreciate clear and simple ingredient lists.

Key Market Players

• Life Extension
• Pure Encapsulations
• Nutricost
• Swanson Health Products
• Douglas Laboratories
• Thorne Research
• NOW Foods
• Jarrow Formulas
• Vital Nutrients
• Integrative Therapeutics

Report Scope:

In this report, the Global Pregnenolone Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pregnenolone Supplements Market, By Form:

• Capsules
• Tablets
• Softgels
• Liquid
• Powder

Pregnenolone Supplements Market, By Distribution Channel:

• Retail Pharmacies
• Online Pharmacies
• Others

Pregnenolone Supplements Market, By Application:

• Memory Enhancement
• Mood and Stress Management
• Hormonal Balance
• Cognitive Support
• Anti-aging
• Others

Pregnenolone Supplements Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pregnenolone Supplements Market.

Available Customizations:

Global Pregnenolone Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pregnenolone Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Form (Capsules, Tablets, Softgels, Liquid, Powder)
  • 5.2.2. By Distribution Channel (Retail Pharmacies, Online Pharmacies, others)
  • 5.2.3. By Application (Memory Enhancement, Mood and Stress Management, Hormonal Balance, Cognitive Support, Anti-aging, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Pregnenolone Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Form
  • 6.2.2. By Distribution Channel
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Pregnenolone Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Form
      • 6.3.1.2.2. By Distribution Channel
      • 6.3.1.2.3. By Application
  • 6.3.2. India Pregnenolone Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Form
      • 6.3.2.2.2. By Distribution Channel
      • 6.3.2.2.3. By Application
  • 6.3.3. Australia Pregnenolone Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Form
      • 6.3.3.2.2. By Distribution Channel
      • 6.3.3.2.3. By Application
  • 6.3.4. Japan Pregnenolone Supplements Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Form
      • 6.3.4.2.2. By Distribution Channel
      • 6.3.4.2.3. By Application
  • 6.3.5. South Korea Pregnenolone Supplements Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Form
      • 6.3.5.2.2. By Distribution Channel
      • 6.3.5.2.3. By Application

7. Europe Pregnenolone Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Form
  • 7.2.2. By Distribution Channel
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pregnenolone Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Form
      • 7.3.1.2.2. By Distribution Channel
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Pregnenolone Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Form
      • 7.3.2.2.2. By Distribution Channel
      • 7.3.2.2.3. By Application
  • 7.3.3. Spain Pregnenolone Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Form
      • 7.3.3.2.2. By Distribution Channel
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Pregnenolone Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Form
      • 7.3.4.2.2. By Distribution Channel
      • 7.3.4.2.3. By Application
  • 7.3.5. United Kingdom Pregnenolone Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Form
      • 7.3.5.2.2. By Distribution Channel
      • 7.3.5.2.3. By Application

8. North America Pregnenolone Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Form
  • 8.2.2. By Distribution Channel
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Pregnenolone Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Form
      • 8.3.1.2.2. By Distribution Channel
      • 8.3.1.2.3. By Application
  • 8.3.2. Mexico Pregnenolone Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Form
      • 8.3.2.2.2. By Distribution Channel
      • 8.3.2.2.3. By Application
  • 8.3.3. Canada Pregnenolone Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Form
      • 8.3.3.2.2. By Distribution Channel
      • 8.3.3.2.3. By Application

9. South America Pregnenolone Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Form
  • 9.2.2. By Distribution Channel
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pregnenolone Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Form
      • 9.3.1.2.2. By Distribution Channel
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Pregnenolone Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Form
      • 9.3.2.2.2. By Distribution Channel
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Pregnenolone Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Form
      • 9.3.3.2.2. By Distribution Channel
      • 9.3.3.2.3. By Application

10. Middle East and Africa Pregnenolone Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Form
  • 10.2.2. By Distribution Channel
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pregnenolone Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Form
      • 10.3.1.2.2. By Distribution Channel
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Pregnenolone Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Form
      • 10.3.2.2.2. By Distribution Channel
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Pregnenolone Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Form
      • 10.3.3.2.2. By Distribution Channel
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Pregnenolone Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Life Extension
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Pure Encapsulations
  • 16.2.1. Business Overview
  • 16.2.2. Company Snapshot
  • 16.2.3. Products & Services
  • 16.2.4. Financials (In case of listed companies)
  • 16.2.5. Recent Developments
  • 16.2.6. SWOT Analysis
• 16.3. Nutricost
  • 16.3.1. Business Overview
  • 16.3.2. Company Snapshot
  • 16.3.3. Products & Services
  • 16.3.4. Financials (In case of listed companies)
  • 16.3.5. Recent Developments
  • 16.3.6. SWOT Analysis
• 16.4. Jarrow Formulas
  • 16.4.1. Business Overview
  • 16.4.2. Company Snapshot
  • 16.4.3. Products & Services
  • 16.4.4. Financials (In case of listed companies)
  • 16.4.5. Recent Developments
  • 16.4.6. SWOT Analysis
• 16.5. Swanson Health Products
  • 16.5.1. Business Overview
  • 16.5.2. Company Snapshot
  • 16.5.3. Products & Services
  • 16.5.4. Financials (In case of listed companies)
  • 16.5.5. Recent Developments
  • 16.5.6. SWOT Analysis
• 16.6. Douglas Laboratories
  • 16.6.1. Business Overview
  • 16.6.2. Company Snapshot
  • 16.6.3. Products & Services
  • 16.6.4. Financials (In case of listed companies)
  • 16.6.5. Recent Developments
  • 16.6.6. SWOT Analysis
• 16.7. Thorne Research,
  • 16.7.1. Business Overview
  • 16.7.2. Company Snapshot
  • 16.7.3. Products & Services
  • 16.7.4. Financials (In case of listed companies)
  • 16.7.5. Recent Developments
  • 16.7.6. SWOT Analysis
• 16.8. NOW Foods
  • 16.8.1. Business Overview
  • 16.8.2. Company Snapshot
  • 16.8.3. Products & Services
  • 16.8.4. Financials (In case of listed companies)
  • 16.8.5. Recent Developments
  • 16.8.6. SWOT Analysis
• 16.9. Vital Nutrients
  • 16.9.1. Business Overview
  • 16.9.2. Company Snapshot
  • 16.9.3. Products & Services
  • 16.9.4. Financials (In case of listed companies)
  • 16.9.5. Recent Developments
  • 16.9.6. SWOT Analysis
• 16.10.Integrative Therapeutics
  • 16.10.1. Business Overview
  • 16.10.2. Company Snapshot
  • 16.10.3. Products & Services
  • 16.10.4. Financials (In case of listed companies)
  • 16.10.5. Recent Developments
  • 16.10.6. SWOT Analysis

17. Strategic Recommendations

18. About Us & Disclaimer